Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed -43.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed -203.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating margin changed -2952 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -103.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -55.1% from the comparable as-filed period.
Revenue changed -20.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +1155 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +31.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -82792 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +23.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -22.0% from the comparable as-filed period.
Current ratio changed +102.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -1732 basis points from the comparable as-filed period.
Working capital / assets changed +899 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -23.1% from the comparable as-filed period.
Current assets changed +13.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -110.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Total assets changed +10.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +3.1% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.